[1] CHEN D,ZHANG X,LI Z,et al.Metabolic regulatory crosstalk between tumor microenvironment and tumor-associated macrophages [J].Theranostics,2021,11(3):1016-1030.
[2] CHEN Z,HAMBARDZUMYAN D.Immune microenvironment in glioblastoma subtypes [J].Front Immunol,2018,9:1004.
[3] HUANG R,KANG T,CHEN S.The role of tumor-associated macrophages in tumor immune evasion [J].J Cancer Res Clin Oncol,2024,150(5):238.
[4] BARTHEL L,HADAMITZKY M,DAMMANN P,et al.Glioma:molecular signature and crossroads with tumor microenvironment [J].Cancer Metastasis Rev,2022,41(1):53-75.
[5] KHAN F,PANG L,DUNTERMAN M,et al.Macrophages and microglia in glioblastoma:heterogeneity,plasticity,and therapy [J].J Clin Invest,2023,133(1):e163446.
[6] KRISHNA S,CHOUDHURY A,KEOUGH MB,et al.Glioblastoma remodelling of human neural circuits decreases survival [J].Nature,2023,617(7961):599-607.
[7] CHEN Z,FENG X,HERTING CJ,et al.Cellular and molecular identity of tumor-associated macrophages in glioblastoma [J].Cancer Res,2017,77(9):2266-2278.
[8] URBANTAT RM,JELGERSMA C,BRANDENBURG S,et al.Tumor-associated microglia/macrophages as a predictor for survival in glioblastoma and temozolomide-induced changes in CXCR2 signaling with new resistance overcoming strategy by combination therapy [J].Int J Mol Sci,2021,22(20):11180.
[9] HAMBARDZUMYAN D,GUTMANN DH,KETTENMANN H.The role of microglia and macrophages in glioma maintenance and progression [J].Nat Neurosci,2016,19(1):20-27.
[10] VECCHIARELLI HA,TREMBLAY M.Local translation in microglial processes [J].Nat Neurosci,2023,26(7):1140-1142.
[11] BORST K,DUMAS AA,PRINZ M.Microglia:Immune and non-immune functions [J].Immunity,2021,54(10):2194-2208.
[12] HINSHAW DC,SHEVDE LA.The tumor microenvironment innately modulates cancer progression [J].Cancer Res,2019,79(18):4557-4566.
[13] HE Z,ZHANG S.Tumor-associated macrophages and their functional transformation in the hypoxic tumor microenvironment [J].Front Immunol,2021,12:741305.
[14] NATHAN CF,MURRAY HW,WIEBE ME,et al.Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity [J].J Exp Med,1983,158(3):670-689.
[15] LI W,YE Q,JIANG Z,et al.A cross-linked macropore hydrogel based on M1 macrophage lysate and alginate regulates tumor-associated macrophages for the treatment of melanoma [J].Int J Biol Macromol,2024,269(Pt 2):132089.
[16] JIANG S,LI W,YANG J,et al.Cathepsin B-responsive programmed brain targeted delivery system for chemo-immunotherapy combination therapy of glioblastoma [J].ACS Nano,2024,18(8):6445-6462.
[17] ELKIN M.Role of heparanase in macrophage activation [J].Adv Exp Med Biol,2020,1221:445-460.
[18] STEIN M,KESHAV S,HARRIS N,et al.Interleukin 4 potently enhances murine macrophage mannose receptor activity:a marker of alternative immunologic macrophage activation [J].J Exp Med,1992,176(1):287-292.
[19] CORNICE J,VERZELLA D,ARBORETTO P,et al.NF-κB:Governing macrophages in cancer [J].Genes (Basel),2024,15(2):197.
[20] PEA-ROMERO AC,ORENES-PIERO E.Dual effect of immune cells within tumour microenvironment:Pro- and anti-tumour effects and their triggers [J].Cancers (Basel),2022,14(7):1681.
[21] SHI T,ZHANG Y,WANG Y,et al.DKK1 promotes tumor immune evasion and impedes anti-PD-1 treatment by inducing immunosuppressive macrophages in gastric cancer [J].Cancer Immunol Res,2022,10(12):1506-1524.
[22] ZHOU P,LI Q,SU S,et al.Interleukin 37 suppresses M1 macrophage polarization through inhibition of the Notch1 and nuclear factor kappa B pathways [J].Front Cell Dev Biol,2020,8:56.
[23] LI M,YANG Y,XIONG L,et al.Metabolism,metabolites,and macrophages in cancer [J].J Hematol Oncol,2023,16(1):80.
[24] BRUNI D,ANGELL HK,GALON J.The immune contexture and immunoscore in cancer prognosis and therapeutic efficacy [J].Nat Rev Cancer,2020,20(11):662-680.
[25] ZHANG L,SHI P,JIN P,et al.Ganodermanontriol regulates tumor-associated M2 macrophage polarization in gastric cancer [J].Aging (Albany NY),2024,16(2):1390-1398.
[26] TAFECH A,STPHANOU A.On the importance of acidity in cancer cells and therapy [J].Biology (Basel),2024,13(4):225.
[27] WENES M,SHANG M,DI MATTEO M,et al.Macrophage metabolism controls tumor blood vessel morphogenesis and metastasis [J].Cell Metabolism,2016,24(5):701-715.
[28] MANTOVANI A,ALLAVENA P.The interaction of anticancer therapies with tumor-associated macrophages [J].J Exp Med,2015,212(4):435-445.
[29] CANLI ,NICOLAS AM,GUPTA J,et al.Myeloid cell-derived reactive oxygen species induce epithelial mutagenesis [J].Cancer Cell,2017,32(6):869-883.e865.
[30] XU D,WANG Y,WU J,et al.ECT2 overexpression promotes the polarization of tumor-associated macrophages in hepatocellular carcinoma via the ECT2/PLK1/PTEN pathway [J].Cell Death Dis,2021,12(2):162.
[31] GORDON S,MARTINEZ FO.Alternative activation of macrophages:mechanism and functions [J].Immunity,2010,32(5):593-604.
[32] MURAILLE E,LEO O,MOSER M.TH1/TH2 paradigm extended:macrophage polarization as an unappreciated pathogen-driven escape mechanism[J].Front Immunol,2014,5:603.
[33] SICA A,MANTOVANI A.Macrophage plasticity and polarization:in vivo veritas [J].J Clin Invest,2012,122(3):787-795.
[34] SCHLEICHER U,PADUCH K,DEBUS A,et al.TNF-mediated restriction of arginase 1 expression in myeloid cells triggers type 2 NO synthase activity at the site of infection [J].Cell Rep,2016,15(5):1062-1075.
[35] MURRAY PJ.Macrophage polarization [J].Annu Rev Physiol,2017,79:541-566.
[36] MA Q,LONG W,XING C,et al.Corrigendum:PHF20 promotes glioblastoma cell malignancies through a WISP1/BGN-dependent pathway [J].Front Oncol,2023,13:1157694.
[37] ZHU CX,YAN K,CHEN L,et al.Targeting OXCT1-mediated ketone metabolism reprograms macrophages to promote antitumor immunity via CD8(+) T cells in hepatocellular carcinoma [J].J Hepatol[2024-05-15].https://pubmed.ncbi.nlm.nih.gov/38759889/.DOI:10.1016/j.jhep.2024.05.007.
[38] 吴从严,楼美清,贾玉,等.肿瘤相关巨噬细胞研究进展[J].现代肿瘤医学,2020,28(3):508-512.
WU Congyan,LOU Meiqing,JIA Yu,et al.Research progression of tumor-associated macrophage[J].Modern Oncology,2020,28(3):508-512.
[39] TANG K,ZHANG H,DENG J,et al.Ammonia detoxification promotes CD8(+) T cell memory development by urea and citrulline cycles [J].Nat Immunol,2023,24(1):162-173.
[40] WANG H,WANG X,ZHANG X,et al.The promising role of tumor-associated macrophages in the treatment of cancer [J].Drug Resist Updat,2024,73:101041.
[41] TANG J,MING L,QIN F,et al.The heterogeneity of tumour-associated macrophages contributes to the clinical outcomes and indications for immune checkpoint blockade in colorectal cancer patients [J].Immunobiology,2024,229(3):152805.
[42] PAN Z,ZHAO R,LI B,et al.EWSR1-induced circNEIL3 promotes glioma progression and exosome-mediated macrophage immunosuppressive polarization via stabilizing IGF2BP3[J].Mol Cancer,2022,21(1):16.
[43] KREATSOULAS D,BOLYARD C,WU BX,et al.Translational landscape of glioblastoma immunotherapy for physicians:guiding clinical practice with basic scientific evidence [J].J Hematol Oncol,2022,15(1):80.
[44] LI Z,FU WJ,CHEN XQ,et al.Autophagy-based unconventional secretion of HMGB1 in glioblastoma promotes chemosensitivity to temozolomide through macrophage M1-like polarization [J].J Exp Clin Cancer Res,2022,41(1):74.
[45] HUANG X,LIN R,LIU H,et al.Resatorvid (TAK-242) ameliorates ulcerative colitis by modulating macrophage polarization and T helper cell balance via TLR4/JAK2/STAT3 signaling pathway [J].Inflammation[2024-05-18].https://pubmed.ncbi.nlm.nih.gov/38760646/.DOI:10.1007/s10753-024-02028-z.
[46] LIU M,LIANG W,SU Y,et al.COL8A1 is a potential prognostic biomarker associated with migration,proliferation,and tumor microenvironment in glioma [J].Exp Cell Res,2024,439(1):114076.
[47] PARK JE,DUTTA B,TSE SW,et al.Hypoxia-induced tumor exosomes promote M2-like macrophage polarization of infiltrating myeloid cells and microRNA-mediated metabolic shift [J].Oncogene,2019,38(26):5158-5173.
[48] YANG YE,HU MH,ZENG YC,et al.IL-33/NF-κB/ST2L/Rab37 positive-feedback loop promotes M2 macrophage to limit chemotherapeutic efficacy in lung cancer [J].Cell Death Dis,2024,15(5):356.
[49] BOUTILIER AJ,ELSAWA F.Macrophage polarization states in the tumor microenvironment [J].Int J Mol Sci,2021,22(13):6995.
[50] LANKADASARI MB,MUKHOPADHYAY P,MOHAMMED S,et al.TAMing pancreatic cancer:combat with a double edged sword [J].Mol Cancer,2019,18(1):48.
[51] 赵昆,时荣臣,缪洪明.肿瘤相关巨噬细胞的脂质代谢重编程[J].四川大学学报(医学版),2021,52(01):45-49.
ZHAO Kun,SHI Rongchen,MIAO Hongming.A review of the lipid metabolism reprogramming in tumor associated macrophages[J].J Sichuan Univ(Med Sci),2021,52(01):45-49.
[52] IYER S,ENMAN M,SAHAY P,et al.Novel therapeutics to treat chronic pancreatitis:targeting pancreatic stellate cells and macrophages [J].Expert Rev Gastroenterol Hepatol,2024,18(4-5):171-183.
[53] YANG F,ZHANG D,JIANG H,et al.Small-molecule toosendanin reverses macrophage-mediated immunosuppression to overcome glioblastoma resistance to immunotherapy [J].Sci Transl Med,2023,15(683):eabq3558.